Shy-Drager Syndrome

Shy-Drager Syndrome is a progressive disorder of the central and sympathetic nervous systems characterized by symptoms of autonomic nervous system failure, impaired speech, difficulties breathing and swallowing, and anhidrosis. Here is the latest research.

March 21, 2019
Open Access

Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis

Clinics
André Luiz Farinhas ToméCristiano Mendes Gomes
February 8, 2019
Review

Droxidopa for the treatment of neurogenic orthostatic hypotension in neurodegenerative diseases

Expert Opinion on Pharmacotherapy
Santiago Pérez-LloretOlivier Rascol
November 22, 2018
Review
Open Access

An update on advances in magnetic resonance imaging of multiple system atrophy

Journal of Neurology
Viorica ChelbanJonathan D Rohrer
July 16, 2020

Sexual Dysfunction in Parkinson Disease: A Multicenter Italian Cross-sectional Study on a Still Overlooked Problem

The Journal of Sexual Medicine
Loredana RacitiRocco Salvatore Calabrò
July 28, 2020

The footprint of orthostatic hypotension in parkinsonian syndromes

Parkinsonism & Related Disorders
Cecilia RaccagniAlessandra Fanciulli
December 7, 2018
Review
Open Access

Modeling Parkinson's Disease and Atypical Parkinsonian Syndromes Using Induced Pluripotent Stem Cells

International Journal of Molecular Sciences
Takayasu MishimaYoshio Tsuboi
January 2, 2019
Open Access

Association of autonomic symptoms with disease progression and survival in progressive supranuclear palsy

Journal of Neurology, Neurosurgery, and Psychiatry
Marcos C B OliveiraThomas T Warner
December 5, 2018
Case Report
Open Access

An autopsy case of progressive multifocal leukoencephalopathy after rituximab therapy for malignant lymphoma

Neuropathology : Official Journal of the Japanese Society of Neuropathology
Reiji MutoKoichi Ohshima
November 27, 2018
Review

Neuroimaging Applications in Chronic Ataxias

International Review of Neurobiology
Mario Mascalchi, Alessandra Vella
August 20, 2020

ERYTHROCYTES AS MARKERS OF OXIDATIVE STRESS RELATED PATHOLOGIES

Mechanisms of Ageing and Development
Luca MassaccesiMassimiliano Marco Corsi Romanelli
February 23, 2020
Open Access

Disease progression and prognostic factors in multiple system atrophy: A prospective cohort study

Neurobiology of Disease
Alexandra Foubert-SamierWassilios G Meissner
July 2, 2020
Open Access

Parkinsonian and Cerebellar Phenotypes of Probable MSA: An Insight in to Prognostic Factors Based on Autonomic Functions

Annals of Indian Academy of Neurology
Malligurki Raghurama RukmaniTalakad N Sathyaprabha
August 6, 2020
Open Access

Effect of cold oral stimulation on orthostatic hypotension in multiple system atrophy: a case study

Journal of Physical Therapy Science
Hironobu UzawaYusuke Nishida
June 4, 2019
Open Access

Magnetic resonance image findings in pug dogs with thoracolumbar myelopathy and concurrent caudal articular process dysplasia

BMC Veterinary Research
Colin J DriverClare Rusbridge
November 14, 2018

The Hippocratic Doctrine of "the Acute Brain Suffering" as the Brain Stroke

Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association
Gregory TsoucalasMarianna Karamanou
October 18, 2019

Long-term trends in myocardial sympathetic innervation and function in synucleinopathies

Parkinsonism & Related Disorders
Guillaume LamotteDavid S Goldstein
May 17, 2019
Open Access

Erectile Dysfunction Preceding Clinically Diagnosed α -Synucleinopathies: A Case-Control Study in Olmsted County

Parkinson's Disease
Shemonti HasanRodolfo Savica
November 23, 2018
Case Report

A case of autoimmune autonomic ganglionopathy with prolonged delirium

Asian Journal of Psychiatry
Shinya UenishiSatoshi Ukai

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/shy-drager-syndrome/0f77dd8c-773a-4061-ba5e-c08ade5f9587